Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PTEN methylation and expression in glioblastomas.

Nathalie Baeza1, Michael Weller, Yasuhiro Yonekawa

  • 1International Agency for Research on Cancer (IARC), 69372, Lyon, France.

Acta Neuropathologica
|August 9, 2003
PubMed
Summary

PTEN promoter methylation frequently occurs in glioblastomas, potentially causing focal loss of PTEN expression. However, the relationship between PTEN gene status and protein loss remains complex and inconsistent.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Reply to Minhas and Tran.

International journal of radiation oncology, biology, physics·2019
Same author

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2018
Same author

Combination Therapy of Intravenously Injected Microglia and Radiation Therapy Prolongs Survival in a Rat Model of Spontaneous Malignant Glioma.

International journal of radiation oncology, biology, physics·2018
Same author

Germline MSH6 Mutation in a Patient With Two Independent Primary Glioblastomas.

Journal of neuropathology and experimental neurology·2017
Same author

CASP9 germline mutation in a family with multiple brain tumors.

Brain pathology (Zurich, Switzerland)·2016
Same author

Braf Mutations Initiate the Development of Rat Gliomas Induced by Postnatal Exposure to N-Ethyl-N-Nitrosourea.

The American journal of pathology·2016

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • The PTEN tumor suppressor gene is crucial for regulating cell growth and apoptosis.
  • PTEN alterations, including mutations, are common in glioblastomas.
  • Epigenetic silencing via promoter methylation is a potential mechanism for PTEN loss.

Purpose of the Study:

  • To investigate the frequency and role of PTEN promoter methylation in glioblastomas.
  • To explore the association between PTEN methylation and loss of PTEN expression.
  • To clarify the relationship between epigenetic and genetic alterations of PTEN in glioblastoma.

Main Methods:

  • Methylation-specific PCR was used to detect PTEN promoter methylation.
  • Immunohistochemistry was employed to assess PTEN protein expression.

Related Experiment Videos

  • Analysis included microdissection of tumor foci with PTEN loss.

    • Main Results:

    • PTEN promoter methylation was found in 35% of glioblastomas and 36% of cell lines.
    • Focal PTEN methylation correlated with focal loss of PTEN expression in tumor biopsies.
    • The correlation between PTEN methylation, mutations, LOH, and protein expression was inconsistent.

    Conclusions:

    • PTEN promoter methylation is a frequent epigenetic event in glioblastomas.
    • PTEN methylation may contribute to focal loss of PTEN expression.
    • Discrepancies between PTEN gene status and protein levels suggest complex regulatory mechanisms and potential confounding factors.